Override unanimous Hold with 50-60% Underweight; 200 SMA break + Q3 catalyst 2-3 weeks out triggers binding 10/06 prescription
The Underweight at 50-60% is the calibrated response that honors the structural-support thesis (no Sell) while arresting the alpha-bleed pathology (no Hold at neutral weight). Mechanical bids ($11B annualized buyback, Polymarket 96% no-cut, $40.6B cash) prevent full Sell; decisive 200 SMA break prevents the 10/02 Hold prescription. Three consecutive Holds at this exact technical posture have produced documented alpha destruction of 1.2-2.4% per cycle. The 10/06 reflection's specific calibration (50-60% aggressive Underweight end) is the operative prescription.
| Position | Action |
|---|---|
| Default to aggressive end of band (50-60% range) | 50-60% of neutral benchmark weight per 10/06 reflection |
| Price stabilizes above $95 | Position at 60% Underweight |
| Price drifts to $93-94 toward lower BB at $92.89 | Position at 50% Underweight |
| Trim incrementally rather than one block | Next two sessions' price action determines exact sizing within 50-60% band |
The technical breakdown is a bear trap; SCHW's record quarterly EPS ($1.54, +42.6% YoY), 12.11x forward P/E with 0.82 PEG ratio, aggressive buybacks ($5.43B H1 2026), and macro tailwinds from higher-for-longer rates create a rare asymmetric setup where the stock wins in both yield scenarios.
| Indicator | Value | Signal |
|---|---|---|
| RSI | 30.35 | bearish |
| MACD | -2.81 | bearish |
| MACD Histogram | -0.48 | bearish |
| 10 EMA | $98.28 | bearish |
| 50 SMA | $105.81 | bearish |
| 200 SMA | $97.88 | neutral |
| Bollinger Middle (20 SMA) | $101.53 | bearish |
| Bollinger Lower | $92.89 | neutral |
| ATR | $2.15 | neutral |
Support: 95.58 · 92.89 · 88.34 | Resistance: 98.28 · 101.53 · 105.81
SCHW exhibits a decisive short-term downtrend following a ~16.5% drawdown from the August peak of $114.53 to the October 7 close at $95.58. Price has broken below all major moving averages (10 EMA at $98.28, 50 SMA at $105.81) and is now testing the critical 200 SMA support at $97.88—down just $2.30. RSI at 30.35 is barely above oversold territory and has compressed in the 29-35 range since September 28, while MACD has been bearish since mid-September with histogram remaining negative for 15 sessions, indicating well-established downside momentum without yet a bullish divergence trigger. The ATR compression to $2.15 suggests an orderly decline rather than panic-driven selling, with next key support at the lower Bollinger Band ($92.89) and the April swing low near $88.34. The overall bias remains bearish until price reclaims the 10 EMA at $98.28 on a daily closing basis.
This report is AI-generated for informational and educational purposes only and is not investment advice or a recommendation to buy or sell any security. Full disclaimer.
When: Close <$95.00 with volume >8M shares
Then: Trim from 50-60% to 40-50% Underweight
Q2 2026 fundamentals are record-breaking and disconnecting from price
EV: +32% · concedes: Technical price action is poor: below 200 SMA, MACD is negative, momentum is poor; Long-end yields at 2002 highs could trigger equity de-rating; Short-term tape-driven negativity exists; Worst-case downside to $88 April low (~8% downside)
The market is repricing SCHW lower because it sees forward earnings power weaker than consensus models; the tape is right and the bull is wrong.
· concedes: Schwab's RIA custody position and scale advantages are real; Q2 2026 was a record quarter — fundamentals in absolute terms are good; Schwab's moat is not narrowing rapidly — it's real but not widening fast enough to offset other risks
→ vs conservative: Waiting for chart improvement treats a 16.5 percent drop as a warning sign rather than a clearance sale on elite fundamentals
→ vs conservative: The 16.5 percent drawdown cited as evidence the market knows something is incorrect—the market is emotional in short run and has mispriced this fundamentally elite franchise
→ vs conservative: Duration risk on 126.6 billion HTM portfolio is a known, priced-in risk actively unwinding quarter by quarter, not a binary threat
→ vs neutral: Calling macro 'cautiously constructive' while S&P 500 and Nasdaq are at record highs and Fed is frozen is cognitive dissonance—the setup is screamingly bullish
→ vs neutral: Waiting for close above 200 SMA, MACD histogram positive, and RSI above 50 is a perfectionist's checklist that guarantees missing the move
Market Capitalization
$165.29 B
Trailing P/E
17.41
Forward P/E
12.11
PEG Ratio
0.82
Price/Book
3.76
EPS (TTM)
$5.49
Forward EPS
$7.90
Dividend Yield
1.32%
Beta
0.78
52-Week Range
$83.96 – $114.53
Book Value/Share
$25.42
Revenue (TTM)
$26.03 B
Gross Profit
$25.37 B
Net Income (TTM)
$9.72 B
Profit Margin
38.8%
Operating Margin
52.3%
Return on Equity
20.3%
Return on Assets
2.07%
Total Assets
$517.3 B
Cash & Equivalents
$40.6 B
Total Stockholders' Equity
$50.1 B
Tangible Book Value
$24.4 B
Total Debt
$37.3 B
2025 Stock Repurchases
$7.35 B
YTD 2026 Buybacks
$5.43 B
Quarterly Dividend
~$640 M
EPS Q2'26 YoY Growth
+42.6%
Net Income Q2'26 YoY Growth
+31.7%
Total Revenue Q2'26 YoY Growth
+20.9%
Net Interest Income Q2'26
$3.36 B
Interest Expense Q2'26
$789 M
Strengths
Concerns
Charles Schwab is in a powerful earnings recovery cycle with Q2'26 revenue up 20.9% YoY to $7.07B and EPS of $1.54 representing a 42.6% YoY jump, validating the post-2023 deposit-stressor recovery thesis. The company trades at just 12.1× forward earnings against 44% expected EPS growth (PEG of 0.82), with a premium 20.3% ROE and 38.8% profit margins that are elite among large-cap financials. Key risks include rate-cut-driven NIM compression, consumer credit deterioration from the growing loan book, and equity market exposure to asset-based revenue, though the strong deposit rebuild, $5.4B in YTD buybacks, and 4× increase in tangible book value since 2022 support the positive fundamental trajectory through 2026–27.
Macro: The macro environment is characterized by a hawkish Fed hold, with 96% probability of zero rate cuts in 2026. The 10-year Treasury yield has reached its highest level since 2002, creating the biggest monthly gain since 2022. Equities (S&P 500 and Nasdaq) are at record highs, though breadth is narrow and tech-led. Inflation is reaccelerating due to geopolitical risks (Iran conflict), with Fed officials publicly stating inflation remains too high. Gold fell on stronger dollar and high yields, confirming a real-rate narrative. Recession odds are low at 6% (down 2pp), supporting a 'higher-for-longer' regime.